Titolo | Pubblicato in | Anno |
---|---|---|
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study | EUROPEAN JOURNAL OF CANCER | 2020 |
Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%. A multicenter study with external validation | JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020 |
Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non–small cell lung cancer | EUROPEAN JOURNAL OF CANCER | 2019 |
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma